Successful treatment of idiopathic thrombocytopenic purpura-like syndrome in a cancer patient with low-dose interferon: Case report and review of the literature

American Journal of Hematology

Volumn 76, Issue 4, 2004, Pages 353-359

  Tsoussis, Sophocles ^a   Ekonomidou, Fotini ^a   Vourliotaki, Erene ^a   Karalis, Ioannis ^a   Dermitzakis, Alkiviades ^a  

^a Medical Oncology Unit   (Greece)

Author keywords

Cancer; Interferon; ITP like syndrome

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

AGED; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG COST; DRUG EFFICACY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; REVIEW;

AGED; AUTOIMMUNE DISEASES; CARCINOMA, SMALL CELL; CYCLOSPORINE; DRUG RESISTANCE; DRUG RESISTANCE, NEOPLASM; FATAL OUTCOME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2B; LUNG NEOPLASMS; MALE; PLATELET COUNT; PREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; VINCRISTINE;

EID: 3342967559     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20116     Document Type: Review

References (38)

1. Klimberg I, Drylie DM. Renal cell carcinoma and idiopathic thrombocytopenic purpura. Urology 1994;23(3):293-296.
2. Rapoport BL, Falkson G, Alberts AS, Eloff P. Idiopathic thrombocytopenic purpura-like syndrome treated with interferon in a patient with lung cancer. Am J Hematol 1990;34:71-72.
3. Tarraza HM, Carroll R, De Cain M, Jones M. Recurrent ovarian carcinoma: presentation as idiopathic thrombocytopenic purpura and a splenic mass. Eur J Gynaecol Oncol 1991;12(6):430-443.
4. Kaneko Y, Murakami H, Matsushima T, et al. Idiopathic thrombocytopenic purpura and monoclonal gammopathy of undermined significance accompanied by urinary bladder carcinoma. Clin Exp Rheumatol 1993;11(2):217.
5. Tsuchishima S, Shimizu T, Yuasa K, et al. Lung cancer surgery in a patient with idiopathic thrombocytopenic purpura (ITP). Kyobu Geka 1998;51(5):424-427.
6. Igarashi T, Itoh K, Fujii H, et al. Successful treatment by radiation and hormone therapy of isolated local recurrence of breast cancer 24 years after mastectomy companied by immune thrombocytopenia: a case report. Jpn J Clin Oncol 1998;28(4):270-275.
7. Nomani Y, Yamashiro T, Yamamoto A, et al. Double lung cancer combined with idiopathic thrombocytopenic purpura. A case report. J Cardiovasc Surg (Torino) 1999;40(6):889-892.
8. Demirer T, Celebi H, Aral M, et al. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999;24(3):335-337.
9. Porrata, LF, Alberts, S, Hook, C, et al. Idiopathic thrombocytopenic purpura associated with breast cancer. A case report and review of the current literature. Am J Clin Oncol (CCT) 1999;22(4):411-413.
10. Wahid FSA, Fun LC, Keng CS, Ismail F. Breast carcinoma presenting as immune thrombocytopenic purpura. Int J Hematol 2001;73:399-400.
11. Kim HD, Boggs DR. A syndrome resembling idiopathic thrombocytopenic purpura in 10 patients with diverse forms of cancer. Am J Med 1979;67:371-377.
12. Spivack M, Brenner SM, Markham MJ, et al. Presumed immune thrombocytopenia and carcinoma: report of three cases and review of the literature. Am J Med Sci 1979;278(2):153-156.
13. Schwartz KA, Slichter SJ, Harker LA. Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumors. Br J Haematol 1982;51:17-24.
14. Bellone JD, Kunicki TJ, Aster RH. Immune thrombocytopenia associated with carcinoma. Ann Intern Med 1983;99:470-472.
15. Garnick MB, Griffin JD. Idiopathic thrombocytopenia in association with extragonadal germ cell cancer. Ann Intern Med 1983;98:926-927.
16. Cummings OW, Mazur MT. Breast carcinoma diffusely metastatic to the spleen. A report of two cases presenting as idiopathic thrombocytopenic purpura. Am J Clin Pathol 1992;97(4):484-489.
17. Theofilopoulos AN, Andrews BJ, Urist MM, et al. The nature of immune complexes in human cancer. J Immunol 1977;119:657-663.
18. Harvath M, Fekete B, Rohoty P. Investigation of circulating complexes in patients with breast cancer. Oncology 1982;39:20-22.
19. Philip TM, Holohan TV, Korac S, et al. The pathophysiology of circulating immune complexes: their role in host-tumor interactions and removal by immunoabsorption. Contemp Top Immunobiol 1985;15:111-137.
20. Warrel RP Jr. Intra-tumoral platelet consumption: the Kasabach-Merritt syndrome as a model for malignant platelet distraction. Prog Clin Biol Res 1982;89:21.
21. Isobe T, Osserman EF. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann NY Acad Sci 1971;190:507-518.
22. Proctor SJ. Alfa interferon therapy in the treatment of idiopathic immune thrombocytopenic purpura. Eur J Cancer 1991;27(Suppl 4):63-68.
23. Fujimura K, Takafura T, Kuriya S, et al. Recombinant human interferon a-2b (rhIFNa-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura (ITP). Am J Hematol 1996;51:37-44.
24. Dubbeld P, Hillen HFP, Schouten HC. Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP). Eur J Haematol 1994;52:233-235.
25. Picozzi VJ, Roeske WR, Creger WP. Fate of therapy failures in adult idiopathic thrombocytopenic purpura. Am J Med 1980;69:690.
26. Mazzucconi MG, Francesconi M, Fidani P, et al. Treatment of idiopathic thrombocytopenic purpura: results of a multicentric protocol. Haematologia 1985;70:329.
27. Bellucci S, Charpak Y, Chastang C, Tobelem G. Low doses v conventional doses corticosteroids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults. Blood 1988;71:1165.
28. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura; a practice guideline developed by explicit methods of the American Society of Hematology. Blood 1996;88:1.
29. Karpatkin S, Strick N, Karpatkin MB, et al. Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med 1972;52:776-785.
30. Jacobs P, Wood L, Novitzky N. Intravenous gamma-globulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomized clinical trial. Am J Med 1994;97:55.
31. Manoharan A. Slow infusion of vincristine in the treatment of idiopathic thrombocytopenic purpura. Am J Hematol 1986;21(2): 135-138.
32. Nomura T, Maekawa T, Uchino H, et al. Clinical usefulness of vinca alkaloid slow infusion in the treatment of chronic refractory idiopathic thrombocytopenic purpura: a multicenter cooperative study. Nippon Ketsueki Gakkai Zasshi 1990;53(1):98-104.
33. Manoharan A. Targeted-immunosuppression with vincristine infusion in the treatment of immune thrombocytopenia. Aust NZJ Med 1991;21(4):405-407.
34. Cervantes F, Montserrat E, Rozman C, et al. Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients. Postgrad Med J 1980;56(660):711-714.
35. Kueh YK. Vincristine therapy in refractory chronic idiopathic thrombocytopenic purpura. Ann Acad Med Singapore 1982;11(2):290-293.
36. Facon T, Caulier MT, Wattel E, et al. A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients. Br J Haematol 1994;86(3):678-680.
37. Kumakura S, Ishikura H, Tsumura H, et al. A favourable effect of long-term a-interferon therapy in refractory idiopathic thrombocytopenic purpura. Br J Haematol 1993;85:805-807.
38. Van Der Harst D, De Jong D, Limpens J, et al. Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura. Blood 1990;76:2321-2326.